About Sarah Cannon

The Sarah Cannon Cancer Institute at HCA Midwest Health, part of the Sarah Cannon Cancer Network, offers access to novel therapies through clinical trials and is providing leading-edge cancer care to patients in our local communities.

In addition to 20+ years of advancing science through clinical research, we:

• Treat 3000+ patients per year on clinical trials
• Are the 2/3 clinical trial leader in the majority of approved cancer therapies over the last 10 years
• Have conducted 260+ first-in-human clinical trials
• Offer 200+ unique agents in trial each year

The Sarah Cannon Cancer Institute at HCA Midwest is a network of hospitals and physicians that brings together the expertise and technology to provide patients throughout our region with a new level of care and support as they face cancer. Our physicians are board-certified in medical oncology, radiation oncology and specialties such as gynecologic oncology and surgery. Our nursing and health staff is comprised of skilled, experienced cancer practitioners.

The Sarah Cannon Cancer Institute at HCA Midwest is a network-accredited cancer program, one of only 63 nationally to earn network accreditation. Accredited by the American College of Surgeons' Commission on Cancer (CoC) quality program, Sarah Cannon Cancer Institute at HCA Midwest Health cancer centers exceed the quality care standards set out by the CoC and consistently provide excellence in the delivery of comprehensive patient-centered care across our network of hospitals.

The Sarah Cannon Cancer Institute at HCA Midwest Health offers a comprehensive range of testing and treatment options, such as inpatient cancer services with a dedicated leukemia/lymphoma unit, surgical services, unparalleled radiation oncology services, and outpatient chemotherapy facilities. Patient navigators and nurse educators are available to help guide patients through their cancer journey from diagnosis through recovery. Additionally, the Sarah Cannon Cancer Institute at HCA Midwest Health offers genetic counseling and specialized treatments such as lymphedema therapy.

Through our physician-led governance and patient-centered care model, the Sarah Cannon Cancer Institute at HCA Midwest Health is driving quality standards and program development. Our recognized physician leadership is embracing new standards of cancer care based on the latest research including the development and implementation of novel targeted therapies, as well as personalized medicine capabilities such as molecular profiling, which tailors treatment plans to the genetic profile of the patient's cancer.

Our established workgroups are organized by disease-site specific cancer programs including breast, complex GI, thoracic, gyneoncology, radiation oncology and managed by a multidisciplinary team of engaged cancer specialists. Our tumor and market conferences connect physicians across HCA Midwest and coordinate optimum patient treatment plans.

The Sarah Cannon Cancer Institute at HCA Midwest Health also offers cancer support, screening and education programs for patients and families.